The bill would expand federal research on endometrial cancer and create a public education program about the disease. It directs the National Institutes of Health (NIH) to coordinate research, share new findings with medical professionals and researchers, and include African-American women in NIH-supported clinical trials in proportion to their share of cases. It also directs the Centers for Disease Control and Prevention (CDC) to develop and share information about cancer rates, risk factors, risks for ethnic minority women, and available treatments, including materials for African-American women. The bill was introduced in the House and referred to the Committee on Energy and Commerce.
If enacted, the bill would make public information about endometrial cancer available and support research and clinical trials. It does not promise a particular treatment or outcome for any person.
The bill authorizes $1 million per year for NIH activities for fiscal years 2026 through 2028. It authorizes such sums as may be necessary for the CDC education program for those years. These are authorizations, not a statement that funds have been provided.
No publicly available information.
No publicly available information.